Cardiff Oncology Cash from Discontinued Operations Adjustment (Quarterly) Insights

Cardiff Oncology, Inc. (CRDF)

2.88 +0.09 (+3.23%) USD | NASDAQ | Jan 16, 16:00

2.80 -0.08 (-2.78%) Pre-Market: 08:08

View Cash from Discontinued Operations Adjustment (Quarterly) for CRDF.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Discontinued Operations Adjustment (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

Start Trial

Agenus, Inc.	--
AIM ImmunoTech, Inc.	--
Perspective Therapeutics, Inc.	--
Protalix Biotherapeutics, Inc.	--
Armata Pharmaceuticals, Inc.	--